Literature DB >> 6461268

Treatment of the Zollinger-Ellison syndrome. A 25 year assessment.

S R Friesen.   

Abstract

An assessment of treatment methods for the Zollinger-Ellison syndrome over 25 years suggests that the dual surgical approach of excision of resectable tumor and total gastrectomy provides the greatest possibility of attaining tumor and serum gastrin control. Normal serum gastrin levels and reduction of tumor status, not observed with nonoperative management, were attained by surgical treatment, particularly when the tumor (or hyperplasia) was limited to the pancreas, stomach, duodenum and regional lymph nodes. Eleven of 16 such operations resulted in tumor control, and 10 of these patients developed normal serum gastrin concentrations. In elective clinical situations combined medical and surgical therapy is a rational approach allowing confirmation of diagnosis and safe, definitive surgical control of the syndrome before metastases occur.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6461268     DOI: 10.1016/0002-9610(82)90102-7

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  24 in total

1.  Parathyroid gastrin and parathormone-producing tumour in the Zollinger-Ellison syndrome of MEN 1 origin.

Authors:  D Santini; G Pasquinelli; L D'Alessandro; G Mazzoleni; M Taffurelli; O Campione; D Marrano; G N Martinelli
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 2.  Unresolved surgical issues in the management of patients with Zollinger-Ellison syndrome.

Authors:  J A Norton; R T Jensen
Journal:  World J Surg       Date:  1991 Jan-Feb       Impact factor: 3.352

3.  Malignant islet-cell tumors of the pancreas.

Authors:  N W Thompson; F E Eckhauser
Journal:  World J Surg       Date:  1984-12       Impact factor: 3.352

4.  Giant gastrinoma in a patient with multiple endocrine adenopathy (type 1).

Authors:  M A Vella; A G Cowie; A N Gorsuch; L C Watson
Journal:  J R Soc Med       Date:  1988-06       Impact factor: 5.344

Review 5.  Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type I.

Authors:  M Pipeleers-Marichal; C Donow; P U Heitz; G Klöppel
Journal:  World J Surg       Date:  1993 Jul-Aug       Impact factor: 3.352

6.  The Zollinger-Ellison syndrome. A collective surgical experience.

Authors:  D R Farley; J A van Heerden; C S Grant; L J Miller; D M Ilstrup
Journal:  Ann Surg       Date:  1992-06       Impact factor: 12.969

7.  Pancreatic tumors in multiple endocrine neoplasia type 1: clinical presentation and surgical treatment.

Authors:  D Grama; B Skogseid; E Wilander; B Eriksson; H Mårtensson; B Cedermark; B Ahrén; A Kristofferson; K Oberg; J Rastad
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

8.  Gastrinomas: a 42-year experience.

Authors:  E L Kaplan; K Horvath; A Udekwu; F Straus; C Schark; D J Ferguson; D B Skinner
Journal:  World J Surg       Date:  1990 May-Jun       Impact factor: 3.352

9.  Surgical treatment of the Zollinger-Ellison syndrome.

Authors:  F Stadil; L Bardram; J Gustafsen; F Efsen
Journal:  World J Surg       Date:  1993 Jul-Aug       Impact factor: 3.352

10.  Curative resection in Zollinger-Ellison syndrome. Results of a 10-year prospective study.

Authors:  J A Norton; J L Doppman; R T Jensen
Journal:  Ann Surg       Date:  1992-01       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.